TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance

References

• Chien Y, Meyer C, Bonneville M. γδ T cells: first line of defense and beyond. Annu Rev Immunol 2014; 32:121–55; PMID:24387714; http://dx.doi.org/10.1146/annurev-immunol-032713-120216
   PubMed Web of Science ®Google Scholar
• Vantourout P, Hayday A. Six-of-the-best: unique contributions of γδ T cells to immunology. Nat Rev Immunol 2013; 13:88–100; PMID:23348415; http://dx.doi.org/10.1038/nri3384
   PubMed Web of Science ®Google Scholar
• Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001; 294:605–9; PMID:11567106; http://dx.doi.org/10.1126/science.1063916
   PubMed Web of Science ®Google Scholar
• Born W, Cady C, Jones-Carson J, Mukasa A, Lahn M, O'Brien R. Immunoregulatory functions of gamma delta T cells. Adv Immunol 1999; 71:77–144; PMID:9917911; http://dx.doi.org/10.1016/S0065-2776(08)60400-9
   PubMedGoogle Scholar
• Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med 2011; 208:491–503; PMID:21383056; http://dx.doi.org/10.1084/jem.20100269
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Kunzmann V, Eckstein S, Reimer P, Weissinger F, Ruediger T, Tony HP. Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood 2003; 102:200–6; PMID:12623838; http://dx.doi.org/10.1182/blood-2002-12-3665
   PubMed Web of Science ®Google Scholar
• Lafarge X, Merville P, Cazin MC, Bergé F, Potaux L, Moreau JF, Déchanet-Merville J. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role. J Infect Dis 2001; 184:533–41; PMID:11494158; http://dx.doi.org/10.1086/322843
   PubMed Web of Science ®Google Scholar
• Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 2007; 27:334–48; PMID:17656116; http://dx.doi.org/10.1016/j.immuni.2007.05.020
   PubMed Web of Science ®Google Scholar
• Brandes M, Willimann K, Moser B. Professional antigen-presentation function by human gammadelta T cells. Science 2005; 309:264–8; PMID:15933162; http://dx.doi.org/10.1126/science.1110267
   PubMed Web of Science ®Google Scholar
• Toulon A, Breton L, Taylor KR, Tenenhaus M, Bhavsar D, Lanigan C, Rudolph R, Jameson J, Havran WL. A role for human skin-resident T cells in wound healing. J Exp Med 2009; 206:743–50; PMID:19307328; http://dx.doi.org/10.1084/jem.20081787
   PubMedGoogle Scholar
• Fisher JP, Heuijerjans J, Yan M, Gustafsson K, Anderson J. γδ T cells for cancer immunotherapy: a systematic review of clinical trials. Oncoimmunology 2014; 3:e27572; PMID:24734216; http://dx.doi.org/10.4161/onci.27572
   PubMed Web of Science ®Google Scholar
• Siegers GM, Lamb LS. Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field? Mol Ther J Am Soc Gene Ther 2014; 22:1416–22; http://dx.doi.org/10.1038/mt.2014.104
   PubMed Web of Science ®Google Scholar
• Déchanet J, Merville P, Lim A, Retière C, Pitard V, Lafarge X, Michelson S, Méric C, Hallet MM, Kourilsky P, et al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest 1999; 103:1437–49; http://dx.doi.org/10.1172/JCI5409
   PubMed Web of Science ®Google Scholar
• Pitard V, Roumanes D, Lafarge X, Couzi L, Garrigue I, Lafon ME, Merville P, Moreau JF, Déchanet-Merville J. Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. Blood 2008; 112:1317–24; PMID:18539896; http://dx.doi.org/10.1182/blood-2008-01-136713
   PubMedGoogle Scholar
• Ehl S, Schwarz K, Enders A, Duffner U, Pannicke U, Kühr J, Mascart F, Schmitt-Graeff A, Niemeyer C, Fisch P. A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest 2005; 115:3140–8; PMID:16211094; http://dx.doi.org/10.1172/JCI25221
   PubMed Web of Science ®Google Scholar
• Knight A, Madrigal AJ, Grace S, Sivakumaran J, Kottaridis P, Mackinnon S, Travers PJ, Lowdell MW. The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood 2010; 116:2164–72; PMID:20576814; http://dx.doi.org/10.1182/blood-2010-01-255166
   PubMed Web of Science ®Google Scholar
• Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M, Van Rysselberge M, Twité N, Goldman M, Marchant A, Willems F. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med 2010; 207:807–21; PMID:20368575; http://dx.doi.org/10.1084/jem.20090348
   PubMed Web of Science ®Google Scholar
• Willcox CR, Pitard V, Netzer S, Couzi L, Salim M, Silberzahn T, Moreau JF, Hayday AC, Willcox BE, Déchanet-Merville J. Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor. Nat Immunol 2012; 13:872–9; PMID:22885985; http://dx.doi.org/10.1038/ni.2394
   PubMed Web of Science ®Google Scholar
• Couzi L, Levaillant Y, Jamai A, Pitard V, Lassalle R, Martin K, Garrigue I, Hawchar O, Siberchicot F, Moore N, et al. Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol 2010; 21:181–8; PMID:19713314; http://dx.doi.org/10.1681/ASN.2008101072
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell 2014; 157:1013–22; PMID:24855941; http://dx.doi.org/10.1016/j.cell.2014.04.007
   PubMed Web of Science ®Google Scholar
• Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell 2002; 10:417–26; PMID:12191486; http://dx.doi.org/10.1016/S1097-2765(02)00599-3
   PubMed Web of Science ®Google Scholar
• De Nardo D, Latz E. NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol 2011; 32:373–9; PMID:21733753; http://dx.doi.org/10.1016/j.it.2011.05.004
   PubMed Web of Science ®Google Scholar
• Henao-Mejia J, Elinav E, Thaiss CA, Flavell RA. Inflammasomes and metabolic disease. Annu Rev Physiol 2014; 76:57–78; PMID:24274736; http://dx.doi.org/10.1146/annurev-physiol-021113-170324
   PubMedGoogle Scholar
• Lartigue L, Faustin B. Mitochondria: metabolic regulators of innate immune responses to pathogens and cell stress. Int J Biochem Cell Biol 2013; 45:2052–6; PMID:23838171; http://dx.doi.org/10.1016/j.biocel.2013.06.014
   PubMedGoogle Scholar
• Schulze A, Harris AL. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 2012; 491:364–73; PMID:23151579; http://dx.doi.org/10.1038/nature11706
   PubMed Web of Science ®Google Scholar
• Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 2008; 26:1179–86; PMID:18820684; http://dx.doi.org/10.1038/nbt.1500
   PubMed Web of Science ®Google Scholar
• Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KSB, McIntire CR, LeBlanc PM, Meunier C, Turbide C, Gros P, Beauchemin N, et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 2010; 32:367–78; PMID:20226691; http://dx.doi.org/10.1016/j.immuni.2010.02.012
   PubMed Web of Science ®Google Scholar
• Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011; 145:745–57; PMID:21565393; http://dx.doi.org/10.1016/j.cell.2011.04.022
   PubMed Web of Science ®Google Scholar
• Doyle SL, Campbell M, Ozaki E, Salomon RG, Mori A, Kenna PF, Farrar GJ, Kiang A-S, Humphries MM, Lavelle EC, et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 2012; 18:791–8; PMID:22484808; http://dx.doi.org/10.1038/nm.2717
   PubMed Web of Science ®Google Scholar
• Lebel-Binay S, Thiounn N, De Pinieux G, Vieillefond A, Debré B, Bonnefoy J-Y, Fridman W-H, Pagès F. IL-18 is produced by prostate cancer cells and secreted in response to interferons. Int J Cancer 2003; 106:827–35; PMID:12918059; http://dx.doi.org/10.1002/ijc.11285
   PubMed Web of Science ®Google Scholar
• Vidal-Vanaclocha F, Mendoza L, Telleria N, Salado C, Valcárcel M, Gallot N, Carrascal T, Egilegor E, Beaskoetxea J, Dinarello CA. Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. Cancer Metastasis Rev 2006; 25:417–34; PMID:17001512; http://dx.doi.org/10.1007/s10555-006-9013-3
   PubMed Web of Science ®Google Scholar
• Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita H, et al. Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells. Cancer Res 2012; 72:2757–67; PMID:22427351; http://dx.doi.org/10.1158/0008-5472.CAN-11-3379
   PubMed Web of Science ®Google Scholar
• Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F, van Bruggen R, Tschopp J. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 2007; 55:443–52; PMID:17164409; http://dx.doi.org/10.1369/jhc.6A7101.2006
   PubMed Web of Science ®Google Scholar
• Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, Frankel G, Levy M, Katz MN, Philbrick WM, et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 2014; 156:1045–59; PMID:24581500; http://dx.doi.org/10.1016/j.cell.2014.01.026
   PubMed Web of Science ®Google Scholar
• Halary F, Pitard V, Dlubek D, Krzysiek R, de la Salle H, Merville P, Dromer C, Emilie D, Moreau JF, Déchanet-Merville J. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J Exp Med 2005; 201:1567–78; PMID:15897274; http://dx.doi.org/10.1084/jem.20041851
   PubMed Web of Science ®Google Scholar
• Yang JH, Zhu HTL, Murphy TLW, Ouyang W, Murphy KM. IL-18-stimulated GADD45 β required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat Immunol 2001; 2:157–64; PMID:11175814; http://dx.doi.org/10.1038/84264
   PubMedGoogle Scholar
• Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front. Immunol 2013; 4:289.
   Google Scholar
• Scheper W, van Dorp S, Kersting S, Pietersma F, Lindemans C, Hol S, Heijhuurs S, Sebestyen Z, Gründer C, Marcu-Malina V, et al. γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia 2013; 27:1328–38; PMID:23277330; http://dx.doi.org/10.1038/leu.2012.374
   PubMed Web of Science ®Google Scholar
• Witherden DA, Verdino P, Rieder SE, Garijo O, Mills RE, Teyton L, Fischer WH, Wilson IA, Havran WL. The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. Science 2010; 329:1205–10; PMID:20813954; http://dx.doi.org/10.1126/science.1192698
   PubMed Web of Science ®Google Scholar
• Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KHG. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009; 31:331–41; PMID:19682929; http://dx.doi.org/10.1016/j.immuni.2009.08.001
   PubMed Web of Science ®Google Scholar
• Rathinam VAK, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010; 11:395–402; PMID:20351692; http://dx.doi.org/10.1038/ni.1864
   PubMed Web of Science ®Google Scholar
• Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature 2012; 481:278–86; PMID:22258606; http://dx.doi.org/10.1038/nature10759
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15:1170–8; PMID:19767732; http://dx.doi.org/10.1038/nm.2028
   PubMed Web of Science ®Google Scholar
• Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, Higashino K, Nakanishi K. IL-18 accounts for both TNF-α-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol 1997; 159:3961–7.
   PubMed Web of Science ®Google Scholar
• Hyodo Y, Matsui K, Hayashi N, Tsutsui H, Kashiwamura S, Yamauchi H, Hiroishi K, Takeda K, Tagawa Y, Iwakura Y, et al. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J Immunol 1999; 162:1662–8; PMID:9973427
   PubMed Web of Science ®Google Scholar
• Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161:3400–7; PMID:9759857
   PubMed Web of Science ®Google Scholar
• Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol 2000; 30:1113–9; PMID:10760800; http://dx.doi.org/10.1002/(SICI)1521-4141(200004)30:4%3c1113::AID-IMMU1113%3e3.0.CO;2-P
   PubMed Web of Science ®Google Scholar
• Nakahira M, Tomura M, Iwasaki M, Ahn HJ, Bian Y, Hamaoka T, Ohta T, Kurimoto M, Fujiwara H. An absolute requirement for STAT4 and a role for IFN-gamma as an amplifying factor in IL-12 induction of the functional IL-18 receptor complex. J Immunol 2001; 167:1306–12; PMID:11466347; http://dx.doi.org/10.4049/jimmunol.167.3.1306
   PubMed Web of Science ®Google Scholar
• Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, Satterthwait AC, Reed JC. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 2003; 423:456–461; PMID:12732850; http://dx.doi.org/10.1038/nature01627
   PubMedGoogle Scholar
• Faustin B, Lartigue L, Bruey J-M, Luciano F, Sergienko E, Bailly-Maitre B, Volkmann N, Hanein D, Rouiller I, Reed JC. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 2007; 25:713–24; PMID:17349957; http://dx.doi.org/10.1016/j.molcel.2007.01.032
   PubMed Web of Science ®Google Scholar